Skip to main content

Pharmacogenomics of Anti-Platelet Intervention (PAPI)

Principal Investigator: Dr. Alan Shuldiner 

The goal of this study is to understand why some people do not respond to commonly used medications to prevent heart attacks including aspirin and clopidogrel (Plavix). This 8-day study involves taking clopidogrel and aspirin and having blood samples tested to see how well the medications prevent the blood from clotting. PAPI participants also receive free testing for heart problems, high cholesterol, liver, kidney, and thyroid problems. To date, more than 650 volunteers have participated in this study.